Food and Drug Administration

Antiviral Drugs Advisory Committee

March 19, 2002

NDA 21-245, Picovir (pleconaril), ViroPharma Incorporated, proposed for treatment of acute picornaviral upper respiratory illness (common cold) in adults


Sponsor Presentation - ViroPharma Incorporated   ppt   htm


The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

Introduction, FDA   ppt     htm

FDA Presentation   ppt    htm

Charge to the Committee, FDA   ppt   htm